Claims for Patent: 8,679,778

Summary for Patent: 8,679,778

Title:	Method for producing a biopolymer (e.g. polypeptide) in a continuous fermentation process
Abstract:	A method for improving productivity in microbial fermentations and mammalian cell culture bioreactors.
Inventor(s):	Laustsen; Mads (Copenhagen, DK)
Assignee:	CMC Biologics A/S (Soeborg, Copenhagen, DK)
Application Number:	12/664,159
Patent Claims:	1. A method for producing a biopolymer of interest in a bioreactor in a continuous perfusion fermentation process, wherein said bioreactor comprises: (i) a cell culture vessel which comprises cells that express the biopolymer of interest in a suitable medium; (ii) an impurity filter unit, comprising an impurity filter, which allows cell waste and impurities with a molecular weight (MW) below the MW of the biopolymer of interest, to be removed while retaining cells and the biopolymer of interest in the vessel, wherein the biopolymer of interest has a MW of at least 2,000 kDa and the impurity filter has a pore size with a nominal molecular weight cut-off (NMWC) within the range of 1,000 kDa to 15,000 kDa, wherein the impurity filter unit is in fluid communication with the medium inside the vessel (i); (iii) a product harvest module, comprising a product filter, wherein the product harvest module allows the biopolymer of interest, cell waste and impurities to be removed from the vessel while retaining cells inside the vessel and wherein the product filter has a pore size with a NMWC within the range of 50,000 kDa to 2 .mu.m, wherein the product harvest module is in fluid communication with the medium inside the vessel (i); wherein the method comprises following steps: (a) fermenting cells in the vessel in at least 50 L of suitable medium under suitable conditions which express the biopolymer of interest, wherein the biopolymer of interest has a MW of at least 2,000 kDa, wherein during the fermentation cell waste, impurities and medium are removed via the impurity filter unit, the biopolymer of interest is harvested via the product harvest module and new medium is added to replace the medium removed through the impurity filter unit and the product harvest module; and (b) isolating the biopolymer of interest from the medium from the product harvest module, wherein the cell density in the vessel during the fermentation reaches at least 10 million cells per ml medium; and wherein impurities and cell waste are removed via the impurity filter unit by a flow rate of medium through the impurity filter that is at least 25% of the flow rate of medium through the product filter of step (a). 2. The method of claim 1, wherein impurities and cell waste are removed via the impurity filter unit by a flow rate through the impurity filter of which is at least twice the flow rate through the product filter. 3. The method of claim 1, wherein the biopolymer of interest has a MW of at least 20,000 kDa. 4. The method of claim 1, wherein the biopolymer of interest is an antibody or fragment thereof, Human growth hormone, Follicle-stimulating hormone, Factor VIII, Erythropoietin (EPO), Granulocyte colony-stimulating factor (G-CSF), alpha-glactosidase A, alpha-L-iduronidase (rhlDU; laronidase), N-acetylgalactosamine-4-sulfatase (rhASB; galsulfase), DNAse, Tissue plasminogen activator (TPA), Glucocerebrosidase, Interferon (IF), Insulin, Insulin derivative, Insulin-like growth factor 1, Tenecteplase, antihemophilic factor, human coagulation factor, Etanercept, Trastuzumab, Infliximab, Basiliximab, Daclizumab or Glucocerebrosidase. 5. The method of claim 1, wherein the cell expressing the polypeptide of interest is at least one cell selected from the group consisting of E. coli, Bacillus, yeast from the genus of Saccharomyces, Pichia, Aspergillus, Fusarium, Kluyveromyces, CHO (Chinese Hamster Ovary) cell, hybridomas, BHK (Baby Hamster Kidney) cell, myeloma cell, HEK-293 cell, human lymphoblastoid cell and a mouse cell. 6. The method of claim 1, wherein there is at least 50 L of medium in the vessel and at least 12 L new medium is added per day which are removed/harvested via the impurity filter and product harvest module in accordance with step (b). 7. The method of claim 1, wherein the isolated biopolymer of interest of step (b) is formulated into a final commercial relevant composition of interest. 8. The method according to claim 1, wherein the cell density in the vessel during the fermentation reaches at least 20 million cells per ml medium. 9. A method for producing a biopolymer of interest in a bioreactor in a continuous perfusion fermentation process, wherein said bioreactor comprises: (i) a cell culture vessel which comprises cells that express the biopolymer of interest in a suitable medium; (ii) an impurity filter unit, comprising an impurity filter, which allows cell waste and impurities with a MW below the MW of the biopolymer of interest, to be removed while retaining cells and the biopolymer of interest in the vessel, wherein the impurity filter has a pore size with a NMWC within the range of 2,000 kDa to 30,000 kDa, wherein the impurity filter unit is in fluid communication with the medium inside the vessel (i); (iii) a product harvest module, comprising a product filter, wherein the product harvest module allows the biopolymer of interest, cell waste and impurities to be removed from the vessel while retaining cells inside the vessel and wherein the product filter has a pore size with a NMWC within the range of 50,000 kDa to 2 .mu.m, wherein the product harvest module is in fluid communication with the medium inside the vessel (i); wherein the method comprises following steps: (a) fermenting cells in the vessel in at least 50 L of suitable medium under suitable conditions which express the biopolymer of interest, wherein during the fermentation cell waste, impurities and medium are removed via the impurity filter unit, the biopolymer of interest is harvested via the product harvest module and new medium is added to replace the medium removed through the impurity filter unit and the product harvest module; and (b) isolating the biopolymer of interest from the medium from the product harvest module, wherein the cell density in the vessel during the fermentation reaches at least 10 million cells per ml medium; and wherein impurities and cell waste are removed via the impurity filter unit by a flow rate of medium through the impurity filter that is at least 25% of the flow rate of medium through the product filter of step (a). 10. A method for producing a biopolymer of interest in a bioreactor in a continuous perfusion fermentation process, wherein said bioreactor comprises: (i) a cell culture vessel which comprises cells that express the biopolymer of interest in a suitable medium; (ii) an impurity filter unit, comprising an impurity filter, which allows cell waste and impurities with a MW below the MW of the biopolymer of interest, to be removed while retaining cells and the biopolymer of interest in the vessel, wherein the impurity filter has a pore size with a NMWC with a maximum of 80% of the molecular weight of the biopolymer of interest, wherein the impurity filter unit is in fluid communication with the medium inside the vessel (i); (iii) a product harvest module, comprising a product filter, wherein the product harvest module allows the biopolymer of interest, cell waste and impurities to be removed from the vessel while retaining cells inside the vessel and wherein the product filter has a pore size with a NMWC of at least 1.5 times the molecular weight of the biopolymer of interest, wherein the product harvest module is in fluid communication with the medium inside the vessel (i); wherein the method comprises following steps: (a) fermenting cells in the vessel in at least 50 L of suitable medium under suitable conditions which express the biopolymer of interest, wherein during the fermentation cell waste, impurities and medium are removed via the impurity filter unit, the biopolymer of interest is harvested via the product harvest module and new medium is added to replace the medium removed through the impurity filter unit and the product harvest module; and (b) isolating the biopolymer of interest from the medium from the product harvest module, wherein the cell density in the vessel during the fermentation reaches at least 10 million cells per ml medium; and wherein impurities and cell waste are removed via the impurity filter unit by a flow rate of medium through the impurity filter that is at least 25% of the flow rate of medium through the product filter of step (a).

Details for Patent 8,679,778

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Grifols Therapeutics Llc	KOATE, KOATE-DVI	antihemophilic factor (human)	For Injection	101130	01/24/1974		2027-06-13
Baxalta Us Inc.	HEMOFIL M	antihemophilic factor (human)	For Injection	101448	03/14/2001		2027-06-13
Hoffmann-la Roche Inc.	ZENAPAX	daclizumab	Injection	103749	12/10/1997		2027-06-13